Romania
M&As this week: TapImmune, CalibreScientific, Medicover Holding
US-based clinical-stage immuno-oncology company TapImmune has signed an agreement to merge with Marker Therapeutics
US-based clinical-stage immuno-oncology company TapImmune has signed an agreement to merge with Marker Therapeutics